AMG 404 in Patients With Advanced Solid Tumors

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2019
To evaluate the safety and tolerability of AMG 404, a monoclonal antibody that binds to PD-1 and inhibits its engagement with ligands, in patients with advanced solid tumors.
Epistemonikos ID: f4004a0cb7c4a77ce7e8eaca7c9cb26f92f50635
First added on: May 22, 2024